Pharma Pulse: Trump’s New Healthcare Roadmap, FDA Vaccine Warnings, and BPD to Lead The Agency Network

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.

• First, President Trump has unveiled "The Great Healthcare Plan," a proposal aimed at slashing prescription costs and maximizing price transparency. The plan seeks to bypass traditional insurance middlemen by allowing the government to pay funds directly into patient health savings accounts.
• On the regulatory front, the FDA has notified manufacturers of six different flu vaccines—including Sanofi and GSK—to add a new warning to their labels. Data from the last two seasons shows a small but increased risk of febrile seizures in children aged six months to four years on the day following vaccination.
• Lastly, BPD Healthcare, a leading health brand strategy and communications firm, announced it will lead The Agency Network, MJH Life Sciences’ pharmaceutical and biotech-focused agency. The integration brings together TAN’s pharmaceutical and biotech commercialization expertise with BPD Healthcare’s experience across health systems, providers and communities, creating a more comprehensive strategic partner for healthcare and life sciences brands.

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed.

You can catch Pharma Pulse directly on Audioboom, Spotify, or iHeart.